Rajeev Saggar
Net worth: 11 M $ as of 2026-05-30
Net worth: 11 M $ as of 2026-05-30
Rajeev Saggar is currently Chief Medical Officer at Liquidia Corp.
since 2022.
Former positions include Vice President-Clinical Development at Theravance Biopharma Us LLC from 2021 to 2022, and Medical Director-Pulmonary Hypertension & Fibrosis at The Banner-University Medical Center.
Education includes a doctorate from the University of California, Irvine.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
LIQUIDIA CORPORATION 0.19% | 2026-04-12 | 173,270 ( 0.19% ) | 11 M $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| LIQUIDIA CORPORATION | Chief Tech/Sci/R&D Officer | 2022-07-17 |
| Companies | Position | End |
|---|---|---|
Theravance Biopharma US, Inc.
Theravance Biopharma US, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development for the treatment in lungs, gastrointestinal tract and infectious diseases | Chief Tech/Sci/R&D Officer | 2022-06-30 |
The Banner-University Medical Center
The Banner-University Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 4 |
|---|---|
University of California, Irvine
University of California, Irvine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Banner-University Medical Center
The Banner-University Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Theravance Biopharma US, Inc.
Theravance Biopharma US, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development for the treatment in lungs, gastrointestinal tract and infectious diseases | Commercial Services |
Liquidia Corp.
Liquidia Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Select your edition
All financial news and data tailored to specific country editions